Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma

Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma

Compartilhe

Publicado por: - Oncologista - CRM 170.446
O Dr. Roberto Pestana (CRM 170.446) é oncologista clínica do centro de oncologia do Hospital Israelita Albert Einstein. Além disso, ele é médico do ambulatório de sarcomas do Hospital Municipal Vila Santa Catarina.